The results show that intratumoral injection of RSL3 significantly decreased tumor growth and, more interestingly, that inhibition of SIRT3 by 3-TYP further attenuated the growth of the implanted tumors (Figure 5A). The gene discussed is SIRT3; the disease is neoplasm.